Your browser doesn't support javascript.
loading
[Potential therapies for COVID-19 cardiovascular complications using artemisinin and its derivatives intervene based on its cardiovascular protection].
Yang, Yuan-Min; Chen, Li-Na; Qu, Shui-Qing; Deng, Shuo-Qiu; Liu, Hui; Wang, Xi; Weng, Xiao-Gang; Wang, Ya-Jie; Zhu, Xiao-Xin; Li, Yu-Jie.
Afiliación
  • Yang YM; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China Artemisinin Research Center, China Academy of Chinese Medical Sciences Beijing 100700, China.
  • Chen LN; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China Artemisinin Research Center, China Academy of Chinese Medical Sciences Beijing 100700, China.
  • Qu SQ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China.
  • Deng SQ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China Artemisinin Research Center, China Academy of Chinese Medical Sciences Beijing 100700, China.
  • Liu H; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China.
  • Wang X; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China School of Pharmacy, Shanxi Medical University Taiyuan 030001, China.
  • Weng XG; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
  • Wang YJ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
  • Zhu XX; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
  • Li YJ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China Artemisinin Research Center, China Academy of Chinese Medical Sciences Beijing 100700, China.
Zhongguo Zhong Yao Za Zhi ; 45(24): 6053-6064, 2020 Dec.
Article en Zh | MEDLINE | ID: mdl-33496147
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Artemisininas / COVID-19 / Cardiopatías Límite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Artemisininas / COVID-19 / Cardiopatías Límite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2020 Tipo del documento: Article País de afiliación: China